GlassScriptPhysician profile
Angela Marshall
NPI 1053797399
$1,441.12
in general payments reported to CMS, 2019-2025
25 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $420 · 2022: $125 · 2023: $46.90 · 2024: $502 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $895.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $193.62 | 2021-2022 | |
| Novo Nordisk INC | $139.83 | 2024-2025 | Wegovy |
| Organogenesis INC. | $134.29 | 2025 | Puraply Wound Matrix |
| Kerecis Limited | $133.07 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $103.41 | 2024-2025 | Collagenase Santyl, Acticoat 4" X 4", Allevyn Life L 15.4x15.4 Ctn10 |
| Abbvie INC. | $99.78 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.25 | 2021-2022 | |
| Redhill Biopharma INC. | $68.11 | 2021 | |
| Biodelivery Sciences International, INC. | $49.78 | 2021 | |
| Mimedx Group, INC. | $43.10 | 2024 | |
| Boston Scientific Corporation | $43.06 | 2025 | General - Pain Management, Patient Trial Kit |
| Reprise Biomedical, INC. | $34.74 | 2025 | Miro3d |
| Exact Sciences Corporation | $33.36 | 2025 | The Cologuard Plus Collection Kit |
| Nevro Corp. | $33.04 | 2022-2023 | Senza |
| Grt US Holding, INC. | $30.02 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $29.04 | 2021-2023 | Ztlido |
| Amgen INC. | $27.66 | 2022 | |
| Glaxosmithkline, LLC. | $25.71 | 2025 | Arexvy, Trelegy Ellipta |
| Urgo Medical North America, LLC | $23.56 | 2024 | Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Dexcom, INC. | $23.39 | 2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $23.06 | 2025 | |
| Eisai INC. | $19.85 | 2021 | |
| Integra Lifesciences Corporation | $16.02 | 2024 | Tcc-Ez |
| Convatec INC. | $14.65 | 2024 | |
| Pfizer INC. | $12.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.